34 Items, 2 Pages <<Prev 1 2 Next>> All
| No. | Name of Lifestyle | Third Class | Second Class | First Class | Type | No. of Studies |
|---|---|---|---|---|---|---|
| 21 | Metformin | Antidiabetic | Drug | Clinical characteristics | Protective factor No statistical significance factor | 2 |
| 22 | Nonaspirin NSAID | Analgesic and anti-inflammatory drugs | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 23 | Other cholesterol-lowering drugs | Cholesterol-lowering drugs | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 24 | Other H2 blockers | Antiulcer drug | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 25 | Statin | Statin | Drug | Clinical characteristics | Protective factor No statistical significance factor | 4 |
| 26 | Statin dose | Statin | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 27 | Statin type | Statin | Drug | Clinical characteristics | Protective factor No statistical significance factor | 1 |
| 28 | Sulphonylurea | Antidiabetic | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 29 | Thiazolidinedione | Antidiabetic | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 30 | Thyroid medication | Thyroid medication | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 31 | Time since first of Anticoagulants | Anticoagulants | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 32 | Warfarin | Anticoagulants | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 33 | yr of Cimetidine | Antiulcer drug | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 34 | yr of H2 blockers | Antiulcer drug | Drug | Clinical characteristics | No statistical significance factor | 1 |